Clinical trial
Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies
NCT01567722
Study timeline
Study start (actual)2013-01-02Date precision: day
Registry last updated2023-03-16
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Cancerunresolved
Lymphomaunresolved
Interventions
DNA analysisGENETIC
RNA analysisGENETIC
gene expression analysisGENETIC
polymorphism analysisGENETIC
flow cytometryOTHER
medical chart reviewOTHER
Sponsors & collaborators
AIDS Malignancy Consortiumlead sponsor
National Cancer Institute (NCI)collaborator
The Emmes Company, LLCcollaborator
AIDS and Cancer Specimen Resourcecollaborator
University of Arkansascollaborator
Mapped research locations
PhiladelphiaPennsylvania, United States2SeattleWashington, United States2New YorkNew York, United States1ChicagoIllinois, United States1Los AngelesCalifornia, United States1St LouisMissouri, United States1MiamiFlorida, United States1Washington D.C.District of Columbia, United States1Chapel HillNorth Carolina, United States1The BronxNew York, United States1New OrleansLouisiana, United States1La JollaCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01567722 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.